Amphotericin B and other polyenes—Discovery, clinical use, mode of action and drug resistance

H Carolus, S Pierson, K Lagrou, P Van Dijck - Journal of Fungi, 2020 - mdpi.com
Although polyenes were the first broad spectrum antifungal drugs on the market, after 70
years they are still the gold standard to treat a variety of fungal infections. Polyenes such as …

[HTML][HTML] The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris

JM Rybak, CA Cuomo, PD Rogers - Current opinion in microbiology, 2022 - Elsevier
Highlights•C. auris exhibits resistance to multiple antifungal agents and represents a public
health threat.•The molecular mechanisms of antifungal resistance observed in C. auris vary …

Structural and mechanistic insights into fungal β-1, 3-glucan synthase FKS1

X Hu, P Yang, C Chai, J Liu, H Sun, Y Wu, M Zhang… - Nature, 2023 - nature.com
The membrane-integrated synthase FKS is involved in the biosynthesis of β-1, 3-glucan, the
core component of the fungal cell wall,. FKS is the target of widely prescribed antifungal …

Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris

H Carolus, D Sofras, G Boccarella, S Jacobs… - Nature …, 2024 - nature.com
Antifungal drug resistance represents a serious global health threat, necessitating new
treatment strategies. Here we investigated collateral sensitivity (CS), in which resistance to …

Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies

H Lu, T Hong, Y Jiang, M Whiteway, S Zhang - Advanced Drug Delivery …, 2023 - Elsevier
Candidiasis is an infection caused by fungi from a Candida species, most commonly
Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on …

Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida auris

H Carolus, D Sofras, G Boccarella… - Nature …, 2024 - nature.com
Candida auris is a growing concern due to its resistance to antifungal drugs, particularly
amphotericin B (AMB), detected in 30 to 60% of clinical isolates. However, the mechanisms …

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical …

TR Rogers, PE Verweij, M Castanheira… - Journal of …, 2022 - academic.oup.com
The increasing incidence and changing epidemiology of invasive fungal infections continue
to present many challenges to their effective management. The repertoire of antifungal drugs …

Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata

E Ksiezopolska, MÀ Schikora-Tamarit, R Beyer… - Current Biology, 2021 - cell.com
Fungal infections are a growing medical concern, in part due to increased resistance to one
or multiple antifungal drugs. However, the evolutionary processes underpinning the …

Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 …

V Di Pilato, G Codda, L Ball, DR Giacobbe, E Willison… - Journal of Fungi, 2021 - mdpi.com
Candida auris is an emerging MDR pathogen raising major concerns worldwide. In Italy, it
was first and only identified in July 2019 in our hospital (San Martino Hospital, Genoa) …

[HTML][HTML] Drug resistance and novel therapeutic approaches in invasive candidiasis

SE Murphy, T Bicanic - Frontiers in cellular and infection microbiology, 2021 - frontiersin.org
Candida species are the leading cause of invasive fungal infections worldwide and are
associated with acute mortality rates of~ 50%. Mortality rates are further augmented in the …